Company Profile
HAORUI ENTERPRISES LLC is an Active Pharmaceutical Ingredients (APIs) supplier. With R&D labs and FDA approved cGMP facilities engaging in organic synthesis, fermentation production, process development and manufacturing. Haorui supplies high quality APIs to pharmaceutical industry and provides technical and regulatory support. All of our products are manufactured within the scope of existing patent laws.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid, 6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,(5R,6S)- |
1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,(5R,6S)-;1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-(1-hydroxyethyl)-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-,[5R-[5α,6α(R*)]]-;(5R,6S)-6-[(1R)-1-Hydroxyethyl]-3-[[2-[(iminomethyl)amino]ethyl]thio]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;MK 0787;N-Formimidoylthienamycin;Imipemide;Imipenem;Tienamycin;Imipenen;127644-14-8;75902-88-4;345631-68-7 |
64221-86-9 | - / 98.0% | Inquiry |
15(S)-15-Methyl prostaglandin |
Prosta-5,13-dien-1-oic acid,9,11,15-trihydroxy-15-methyl-,methyl ester,(5Z,9α,11α,13E,15S)-;(15S)-15-Methyl-PGF2α methyl ester;(15S)-15-Methylprostaglandin F2α methyl ester;U 36384;Methyl carboprost;cis-Methyl carboprost;Carboprost methyl ester;98114-69-3;37467-76-8 |
35700-21-1 | - / 98.0% | Inquiry |
2-Acetamido-2-deoxy-D-glucose |
D-Glucose,2-(acetylamino)-2-deoxy-;D-Glucose,2-acetamido-2-deoxy-;2-(Acetylamino)-2-deoxy-D-glucose;N-Acetyl-D-glucosamine;2-Acetamido-2-deoxy-D-glucose;Acetylglucosamine;N-Acetylglucosamine;N-Acetyl-2-amino-2-deoxy-D-glucose;N-Acetyl-2-amino-2-deoxyglucose;2-Acetamido-D-glucose;2-Acetamido-2-deoxyglucose;D-N-Acetylglucosamine;Marine Sweet;NSC 524344;Bio-NAG;GreenNAG;Marine Sweet YSK;MarineSweet F;98632-70-3;134-61-2;7132-76-5;173382-53-1;948887-87-4 |
7512-17-6 | - / 98.0% | Inquiry |
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahy droxy-7-(methylamino)-1,11-dioxo-, [4S-(4a,4aa,5aa,12aa)]- |
Unii-fyy3R43wgo;MinocyclineEPIMpurityC;7-MonodemethylMinocycline;7-MonodemethylMinocyclineDISCONTINUED;7-Methylamino-6-deoxy-6-demethyltetracycline;4S-(4α,4aα,5aα,12aα)]-4-(DiMethylaMino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-7-(MethylaMino)-1,11-dioxo-2-naphthacenecarboxaMide;4S-(4a,4aa,5aa,12aa)]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-7-(methylamino)-1,11-dioxo-2-naphthacenecarboxamide |
4708-96-7 | - / 98.0% | Inquiry |
5-Aza-2'-deoxycytidine |
1,3,5-Triazin-2(1H)-one,4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-;s-Triazin-2(1H)-one,4-amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-;4-Amino-1-(2-deoxy-β-D-erythro-pentofuranosyl)-1,3,5-triazin-2(1H)-one;5-Aza-2′-deoxycytidine;5-Azadeoxycytidine;2-Desoxy-5-azacytidine;2′-Deoxy-5-azacytidine;Decitabine;NSC 127716;DAC;Dacogen;β-Decitabine;5-Aza-2-deoxycytidine;4-Amino-1-(2-deoxy-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one;A 2232;NSC127716;105597-46-4;123795-43-7 |
2353-33-5 | - / 98.0% | Inquiry |
Adenosine |
Adenosine;Adenine riboside;9-β-D-Ribofuranosyladenine;β-D-Adenosine;9H-Purin-6-amine,9-β-D-ribofuranosyl-;β-D-Ribofuranose,1-(6-amino-9H-purin-9-yl)-1-deoxy-;β-D-Ribofuranoside,adenine-9;β-Adenosine;Boniton;Myocol;Nucleocardyl;Sandesin;Riboadenosine;9-β-D-Ribofuranosyl-9H-purin-6-amine;D-Adenosine;Adenocard;Adenoscan;Adrekar;Adenocor;NSC 7652;24: PN: WO2007053194 SEQID: 49 claimed sequence;26: PN: WO2007053194 SEQID: 49 claimed sequence;27: PN: WO2007053194 SEQID: 49 claimed sequence;Adenogesic;NQZ-012;46946-45-6;46969-16-8 |
58-61-7 | - / 98.0% | Inquiry |
Alanyl-glutamine |
L-Glutamine,L-alanyl-;L-Glutamine,N2-L-alanyl-;Glutamine,N2-L-alanyl-;L-Alanyl-L-glutamine;Dipeptiven;Dipeptamin;L-Ala-L-Gln;72: PN: US20070066537 PAGE: 17 claimed protein;GlutaMAX;Glutamax I;Alanyl-glutamine;96: PN: WO2011146121 PAGE: 115 claimed sequence;Sustamine;63: PN: WO2020097235 SEQID: 292 claimed protein |
39537-23-0 | - / 98.0% | Inquiry |
Aliskiren hemifumarate |
Benzeneoctanamide,δ-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-,(αS,γS,δS,ζS)-,(2E)-2-butenedioate (2:1);Benzeneoctanamide,δ-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-,[αS-(αR*,γR*,δR*,ζR*)]-,(E)-2-butenedioate (2:1) (salt);Benzeneoctanamide,δ-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-γ-hydroxy-4-methoxy-3-(3-methoxypropoxy)-α,ζ-bis(1-methylethyl)-,(αS,γS,δS,ζS)-,(2E)-2-butenedioate (2:1) (salt);Aliskiren hemifumarate;Aliskiren fumarate |
173334-58-2 | - / 98.0% | Inquiry |
Amphotericin B |
Amphotericin B;Fungizone;14,39-Dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid,33-[(3-amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-,(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-;Fungilin;Ampho-Moronal;(1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(3-Amino-3,6-dideoxy-β-D-mannopyranosyl)oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid;AmBisome;NS 718;Abelcet;LNS-AmB;Halizon;Amphozone;Amphocin;NSC 527017;Apothecon;Fungizona;Abelecet;Kalsome 10;1407-52-9;8055-20-7;30782-62-8;54482-28-9;170451-78-2;1802392-71-7 |
1397-89-3 | - / 98.0% | Inquiry |
Atorvastatin calcium |
1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),(βR,δR)-;1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),[R-(R*,R*)]-;CI 981;Atorvastatin calcium;YM 548;Lipitor;Atorvastatin hemicalcium;Tahor;Sortis;Atorvastatin hemicalcium salt;Storvas;Rotacor;Atocor;Atoraz;Lowlip;Lorvast;334757-04-9;1108202-55-6;1370463-14-1 |
134523-03-8 | - / 98.0% | Inquiry |
Atracurium besylate |
Isoquinolinium,2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,benzenesulfonate (1:2);Isoquinolinium,2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-,dibenzenesulfonate;Atracurium besylate;BW 33A;Atracurium dibesylate;Tracrium;Atracurium besilate;Atracurium dibesilate;Wellcome 33A74;Tracur |
64228-81-5 | - / 98.0% | Inquiry |
Aztreonam |
Propanoic acid,2-[[(Z)-[1-(2-amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methyl-;Propanoic acid,2-[[[1-(2-amino-4-thiazolyl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene]amino]oxy]-2-methyl-,[2S-[2α,3β(Z)]]-;2-[[(Z)-[1-(2-Amino-4-thiazolyl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfo-3-azetidinyl]amino]-2-oxoethylidene]amino]oxy]-2-methylpropanoic acid;SQ 26776;Azthreonam;Antibiotic Squibb 26,776;Squibb 26776;Aztreonam;Nebactam;Aztreon;Primbactam;Azonam |
78110-38-0 | - / 98.0% | Inquiry |
Beraprost |
1H-Cyclopenta[b]benzofuran-5-butanoic acid,2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-yn-1-yl)-;1H-Cyclopenta[b]benzofuran-5-butanoic acid,2,3,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-;2,3,3a,8b-Tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-yn-1-yl)-1H-cyclopenta[b]benzofuran-5-butanoic acid;Beraprost;ML 1229;MDL 201229 |
88430-50-6 | - / 98.0% | Inquiry |
Bicalutamide |
Propanamide,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-;Propanamide,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-,(±)-;N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide;ICI 176334;Casodex;(±)-4′-Cyano-α,α,α-trifluoro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide;Bicalutamide;Cosudex;ZD 176334;Casode;151262-58-7 |
90357-06-5 | - / 98.0% | Inquiry |
Bimatoprost |
5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-,(5Z)-;5-Heptenamide,7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-,[1R-[1α(Z),2β(1E,3S*),3α,5α]]-;5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-,(5Z)-;(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide;Bimatoprost;AGN 192024;Lumigan;Prostamide;Latisse;17-Phenyltrinor-PGF2α ethylamide;267244-98-4 |
155206-00-1 | - / 98.0% | Inquiry |
Bleomycin sulfate |
Bleomycin,sulfate (salt);Bleomycin sulfate;Blenoxane;Blexane;134171-41-8 |
9041-93-4 | - / 98.0% | Inquiry |
Bortezomib |
Boronic acid,B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;Boronic acid,[3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-,[S-(R*,S*)]-;Boronic acid,[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-;B-[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid;PS 341;PS 341 (pharmaceutical);MG 341;LDP 341;Bortezomib;MLN 341;Velcade;NSC 681239;DPBA;Radiciol;PS 314;Brotezamide;197730-97-5 |
179324-69-7 | - / 98.0% | Inquiry |
Cabazitaxel |
Benzenepropanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,(αR,βS)-;Benzenepropanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4,6-dimethoxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,[2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-;TXD 258;Cabazitaxel;XRP 6258;Jevtana;DEP cabazitaxel;890654-44-1 |
183133-96-2 | - / 98.0% | Inquiry |
Capastat sulfate |
Capreomycin,sulfate (salt);Capastat sulfate;Capreomycin sulfate;Caprocin |
1405-37-4 | - / 98.0% | Inquiry |
Capecitabine |
Cytidine,5′-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]-;Carbamic acid,[1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-,pentyl ester;5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine;Ro 09-1978/000;Capecitabine;Ro 09-1978;5′-Deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine;Xeloda;Capecitibine;Capecytabine;Capiibine;Captabin;N4-Pentyloxycarbonyl-5′-deoxy-5-fluorocytidine;Capacetrine;Ecansya;Capecitabine Medac;Capecitabine Accord;Capecitabine Teva;Capecitabine SUN;Xeltabin;158798-73-3;958887-39-3 |
154361-50-9 | - / 98.0% | Inquiry |